Innovation Medical Management Co .,Ltd.

🇨🇳China
Ownership
-
Established
2003-09-30
Employees
36
Market Cap
-
Website
http://www.chxyl.com
Introduction

The company was founded in April 1997, completed its initial public offering of shares and listed on September 25, 2007. As the reform of the medical service industry continues to deepen, excellent private hospitals will achieve rapid development, and the profitability of target hospitals will continue to increase steadily in subsequent years. After the tran...

Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes

Phase 4
Completed
Conditions
Interventions
First Posted Date
2007-05-04
Last Posted Date
2008-04-01
Lead Sponsor
Innovative Medical
Target Recruit Count
36
Registration Number
NCT00469573
Locations
🇺🇸

South Shore Eye Care, Wantagh, New York, United States

Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness

Phase 4
Completed
Conditions
First Posted Date
2007-05-04
Last Posted Date
2007-09-10
Lead Sponsor
Innovative Medical
Registration Number
NCT00469521
Locations
🇺🇸

Magill Research Center Institute MUSC, Charleston, South Carolina, United States

Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars

Phase 4
Completed
Conditions
Interventions
First Posted Date
2007-03-22
Last Posted Date
2008-09-25
Lead Sponsor
Innovative Medical
Target Recruit Count
12
Registration Number
NCT00450775
Locations
🇺🇸

Dadeland Dermatology, Coral Gables, Florida, United States

Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation

Phase 4
Completed
Conditions
First Posted Date
2007-02-09
Last Posted Date
2007-09-10
Lead Sponsor
Innovative Medical
Registration Number
NCT00433225
Locations
🇺🇸

Ophthalmic Consultants of Long Island, Rockville Centre, New York, United States

Therapeutic Variables in Cataract Surgery

Phase 4
Completed
Conditions
First Posted Date
2006-12-04
Last Posted Date
2007-08-21
Lead Sponsor
Innovative Medical
Registration Number
NCT00407017
Locations
🇺🇸

The Center for Excellence in Eye Care, Miami, Florida, United States

Comparison of Frequency of Use of Optive and Systane

Phase 4
Completed
Conditions
First Posted Date
2006-12-04
Last Posted Date
2007-06-01
Lead Sponsor
Innovative Medical
Registration Number
NCT00406510
Locations
🇺🇸

Private Practice, Azusa, California, United States

Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms

Phase 4
Completed
Conditions
Interventions
First Posted Date
2006-11-30
Last Posted Date
2010-02-22
Lead Sponsor
Innovative Medical
Target Recruit Count
50
Registration Number
NCT00405457
Locations
🇺🇸

Minnesota Eye Consultants, Minneapolis, Minnesota, United States

A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

Phase 4
Completed
Conditions
First Posted Date
2006-11-14
Last Posted Date
2007-08-21
Lead Sponsor
Innovative Medical
Registration Number
NCT00399230
Locations
🇺🇸

Dr. Rajpal, McLean, Virginia, United States

Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms

Phase 4
Completed
Conditions
Interventions
First Posted Date
2006-11-14
Last Posted Date
2008-09-25
Lead Sponsor
Innovative Medical
Target Recruit Count
55
Registration Number
NCT00399061
Locations
🇺🇸

Dr. Schultze, Slingerlands, New York, United States

Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia

Phase 4
Completed
Conditions
First Posted Date
2006-10-03
Last Posted Date
2007-02-13
Lead Sponsor
Innovative Medical
Registration Number
NCT00383396
Locations
🇺🇸

Dr. Schechter, Boynton Beach, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath